Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebralvenous thrombosis 1 month after resumption of the medication at the age of50

Authors
Tormene, D Simioni, P Sartori, MT Girolami, A
Citation
D. Tormene et al., Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebralvenous thrombosis 1 month after resumption of the medication at the age of50, BL COAG FIB, 12(2), 2001, pp. 161-162
Citations number
14
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
BLOOD COAGULATION & FIBRINOLYSIS
ISSN journal
09575235 → ACNP
Volume
12
Issue
2
Year of publication
2001
Pages
161 - 162
Database
ISI
SICI code
0957-5235(200103)12:2<161:HCOGPM>2.0.ZU;2-K